Showing results (621-630 of 919) with videos related to

Sort By:
Pageof 92
Journal of Neurosurgery. Case Lessons|July 1, 2023
Detailed molecular and pathological analyses of primary intracranial embryonal rhabdomyosarcoma with a BRAF mutation: illustrative caseMasamichi Abe, Takahiro Ono, Felix Hinz, et al.
Journal of Cardiology|January 31, 2022
Initial practice of left atrial appendage closure device in Japan; single-center experienceMasato Fukunaga, Akihiro Isotani, Shinichi Shirai, et al.
American Journal of Clinical Pathology|May 15, 2015
p16/CDKN2A FISH in Differentiation of Diffuse Malignant Peritoneal Mesothelioma From Mesothelial Hyperplasia and Epithelial Ovarian CancerTomohiro Ito, Makoto Hamasaki, Shinji Matsumoto, et al.
Cancer Gene Therapy|August 7, 2010
Combinatory cytotoxic effects produced by E1B-55kDa-deleted adenoviruses and chemotherapeutic agents are dependent on the agents in esophageal carcinomaG Ma, K Kawamura, Q Li, et al.
BMC Cancer|June 11, 2015
Cytotoxic effects of replication-competent adenoviruses on human esophageal carcinoma are enhanced by forced p53 expressionShan Yang, Kiyoko Kawamura, Shinya Okamoto, et al.
Internal Medicine (Tokyo, Japan)|March 4, 2014
Neurolymphomatosis in a patient with extranodal NK/T-cell lymphoma, nasal-type: a case report and literature reviewIkuo Shimizu, Yujiro Hamano, Shunichi Sato, et al.
Cancer Reports (Hoboken, N.J.)|December 26, 2024
Efficacy of Combined Encorafenib and Binimetinib Treatment for Erdheim-Chester Disease Harboring Concurrent BRAFV600E and KRASG12R Mutations: A Case ReportYuto Hibino, Rika Sakai, Hiroyuki Takahashi, et al.
Oncology Reports|February 3, 2007
Cytological findings of pre-invasive bronchial lesions detected by light-induced fluorescence endoscopy in a lung cancer screening systemMasayuki Baba, Akira Iyoda, Yasushi Nomoto, et al.
Molecular Ecology|March 30, 2007
Cospeciation in the triplex symbiosis of termite gut protists (Pseudotrichonympha spp.), their hosts, and their bacterial endosymbiontsS Noda, O Kitade, T Inoue, et al.
Plos One|April 5, 2013
Zoledronic acid produces combinatory anti-tumor effects with cisplatin on mesothelioma by increasing p53 expression levelsShinya Okamoto, Yuanyuan Jiang, Kiyoko Kawamura, et al.
Pageof 92